Trial Profile
FazaClo [clozapine] Outcomes in the Control of Schizophrenia (FOCUS)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2008
Price :
$35
*
At a glance
- Drugs Clozapine (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Acronyms FOCUS
- Sponsors Azur Pharma
- 13 Jun 2008 New trial record.